VoxNeuro develops EEG-based brain performance software, with its first in-clinic product VoxNeuro CORE leveraging event-related potentials (ERPs) to provide clinicians with easy-to-interpret cognitive reports. Backed by 40 years of research, the company offers objective cognitive health assessments and is developing a machine-learning enhancement to increase precision and specificity. Recent commercial efforts include securing ten new client agreements and partnerships with academic and clinical stakeholders such as Boston University. VoxNeuro plans to scale clinical installations across the US and advance software through ongoing R&D. The company emphasizes brain health equity and aims to improve patient outcomes by integrating objective data into clinical workflows. VoxNeuro commercializes the world’s first objective Cognitive Health Assessments™: EEG-based neuroimaging that identifies specific areas of brain function impacted by acquired brain injuries, including concussions. Its patient reports are designed to empower clinicians to make informed decisions, accelerate rehabilitation, and track recovery with greater precision. The technology was developed on more than 25 years of globally funded, peer-reviewed research and is founded on the work of neuroscientist Dr. John F. Connolly at McMaster University. VoxNeuro opened its first assessment centre in Hamilton earlier this year and integrates its assessment systems into existing clinics and hospitals. The company says it already has a growing list of clients and plans to scale across Canada and the U.S. within the next 18 months. With recent government support, VoxNeuro intends to build scalable infrastructure, create jobs, and accelerate its clinical impact on brain-injury management.

Total raised

$4M

Funding rounds

2

Latest round

Equity

Latest activity

Aug 2023